Performance of Pyridylthiourea‐Polyethylenimine Polyplex for siRNA‐Mediated Liver Cancer Therapy in Cell Monolayer, Spheroid, and Tumor Xenograft Models

Medical application of siRNAs relies on methods for delivering nucleic acids into the cytosol. Synthetic carriers, which assemble with nucleic acids into delivery systems, show promises for cancer therapy but efficiency remains to be improved. In here, the effectiveness of pyridylthiourea‐polyethyle...

Full description

Bibliographic Details
Main Authors: Jean Baptiste Gossart, Etienne Pascal, Florent Meyer, Emilie Heuillard, Mathieu Gonçalves, Francine Gossé, Eric Robinet, Benoît Frisch, Cendrine Seguin, Guy Zuber
Format: Article
Language:English
Published: Wiley 2017-07-01
Series:Global Challenges
Subjects:
Online Access:https://doi.org/10.1002/gch2.201700013
_version_ 1797743696932765696
author Jean Baptiste Gossart
Etienne Pascal
Florent Meyer
Emilie Heuillard
Mathieu Gonçalves
Francine Gossé
Eric Robinet
Benoît Frisch
Cendrine Seguin
Guy Zuber
author_facet Jean Baptiste Gossart
Etienne Pascal
Florent Meyer
Emilie Heuillard
Mathieu Gonçalves
Francine Gossé
Eric Robinet
Benoît Frisch
Cendrine Seguin
Guy Zuber
author_sort Jean Baptiste Gossart
collection DOAJ
description Medical application of siRNAs relies on methods for delivering nucleic acids into the cytosol. Synthetic carriers, which assemble with nucleic acids into delivery systems, show promises for cancer therapy but efficiency remains to be improved. In here, the effectiveness of pyridylthiourea‐polyethylenimine (πPEI), a siRNA carrier that favors both polyplex disassembly and endosome rupture upon sensing the acidic endosomal environment, in 3 experimental models of hepatocellular cancer is tested. The πPEI‐assisted delivery of a siRNA targeting the polo‐like kinase 1 into Huh‐7 monolayer produces a 90% cell death via a demonstrated RNA interference mechanism. Incubation of polyplex with Huh‐7 spheroids leads to siRNA delivery into the superficial first cell layer and a 60% reduction in spheroid growth compared to untreated controls. Administration of polyplexes into mice bearing subcutaneous implanted Huh‐7Luc tumors results in a reduced tumor progression, similar to the one observed in the spheroid model. Altogether, these results support the in vivo use of synthetic and dedicated polymers for increasing siRNA‐mediated gene knockdown, and their clinical promise in cancer therapeutics.
first_indexed 2024-03-12T14:59:09Z
format Article
id doaj.art-0c8fe974fe604868974348546fcd08f3
institution Directory Open Access Journal
issn 2056-6646
language English
last_indexed 2024-03-12T14:59:09Z
publishDate 2017-07-01
publisher Wiley
record_format Article
series Global Challenges
spelling doaj.art-0c8fe974fe604868974348546fcd08f32023-08-14T09:40:43ZengWileyGlobal Challenges2056-66462017-07-0114n/an/a10.1002/gch2.201700013Performance of Pyridylthiourea‐Polyethylenimine Polyplex for siRNA‐Mediated Liver Cancer Therapy in Cell Monolayer, Spheroid, and Tumor Xenograft ModelsJean Baptiste Gossart0Etienne Pascal1Florent Meyer2Emilie Heuillard3Mathieu Gonçalves4Francine Gossé5Eric Robinet6Benoît Frisch7Cendrine Seguin8Guy Zuber9Université de Strasbourg‐CNRS CAMB UMR 7199 Faculté de Pharmacie 74 route du Rhin 67400 Illkirch FranceUniversité de Strasbourg‐CNRS CAMB UMR 7199 Faculté de Pharmacie 74 route du Rhin 67400 Illkirch FranceUniversité de Strasbourg‐INSERM UMRS 1121 Biomaterials and Bioengineering, FTMS 11 rue Humann 67000 Strasbourg FranceInstitut Hospitalo‐Universitaire de Strasbourg 1 place de l'Hôpital 67000 Strasbourg FranceInstitut Hospitalo‐Universitaire de Strasbourg 1 place de l'Hôpital 67000 Strasbourg FranceInstitut Hospitalo‐Universitaire de Strasbourg 1 place de l'Hôpital 67000 Strasbourg FranceInstitut Hospitalo‐Universitaire de Strasbourg 1 place de l'Hôpital 67000 Strasbourg FranceUniversité de Strasbourg‐CNRS CAMB UMR 7199 Faculté de Pharmacie 74 route du Rhin 67400 Illkirch FranceUniversité de Strasbourg‐CNRS CAMB UMR 7199 Faculté de Pharmacie 74 route du Rhin 67400 Illkirch FranceUniversité de Strasbourg‐CNRS, UMR 7242 Boulevard Sebastien Brant 67400 Illkirch FranceMedical application of siRNAs relies on methods for delivering nucleic acids into the cytosol. Synthetic carriers, which assemble with nucleic acids into delivery systems, show promises for cancer therapy but efficiency remains to be improved. In here, the effectiveness of pyridylthiourea‐polyethylenimine (πPEI), a siRNA carrier that favors both polyplex disassembly and endosome rupture upon sensing the acidic endosomal environment, in 3 experimental models of hepatocellular cancer is tested. The πPEI‐assisted delivery of a siRNA targeting the polo‐like kinase 1 into Huh‐7 monolayer produces a 90% cell death via a demonstrated RNA interference mechanism. Incubation of polyplex with Huh‐7 spheroids leads to siRNA delivery into the superficial first cell layer and a 60% reduction in spheroid growth compared to untreated controls. Administration of polyplexes into mice bearing subcutaneous implanted Huh‐7Luc tumors results in a reduced tumor progression, similar to the one observed in the spheroid model. Altogether, these results support the in vivo use of synthetic and dedicated polymers for increasing siRNA‐mediated gene knockdown, and their clinical promise in cancer therapeutics.https://doi.org/10.1002/gch2.201700013delivery systemliver cancerpolo‐like kinasepolyethyleniminesiRNA
spellingShingle Jean Baptiste Gossart
Etienne Pascal
Florent Meyer
Emilie Heuillard
Mathieu Gonçalves
Francine Gossé
Eric Robinet
Benoît Frisch
Cendrine Seguin
Guy Zuber
Performance of Pyridylthiourea‐Polyethylenimine Polyplex for siRNA‐Mediated Liver Cancer Therapy in Cell Monolayer, Spheroid, and Tumor Xenograft Models
Global Challenges
delivery system
liver cancer
polo‐like kinase
polyethylenimine
siRNA
title Performance of Pyridylthiourea‐Polyethylenimine Polyplex for siRNA‐Mediated Liver Cancer Therapy in Cell Monolayer, Spheroid, and Tumor Xenograft Models
title_full Performance of Pyridylthiourea‐Polyethylenimine Polyplex for siRNA‐Mediated Liver Cancer Therapy in Cell Monolayer, Spheroid, and Tumor Xenograft Models
title_fullStr Performance of Pyridylthiourea‐Polyethylenimine Polyplex for siRNA‐Mediated Liver Cancer Therapy in Cell Monolayer, Spheroid, and Tumor Xenograft Models
title_full_unstemmed Performance of Pyridylthiourea‐Polyethylenimine Polyplex for siRNA‐Mediated Liver Cancer Therapy in Cell Monolayer, Spheroid, and Tumor Xenograft Models
title_short Performance of Pyridylthiourea‐Polyethylenimine Polyplex for siRNA‐Mediated Liver Cancer Therapy in Cell Monolayer, Spheroid, and Tumor Xenograft Models
title_sort performance of pyridylthiourea polyethylenimine polyplex for sirna mediated liver cancer therapy in cell monolayer spheroid and tumor xenograft models
topic delivery system
liver cancer
polo‐like kinase
polyethylenimine
siRNA
url https://doi.org/10.1002/gch2.201700013
work_keys_str_mv AT jeanbaptistegossart performanceofpyridylthioureapolyethyleniminepolyplexforsirnamediatedlivercancertherapyincellmonolayerspheroidandtumorxenograftmodels
AT etiennepascal performanceofpyridylthioureapolyethyleniminepolyplexforsirnamediatedlivercancertherapyincellmonolayerspheroidandtumorxenograftmodels
AT florentmeyer performanceofpyridylthioureapolyethyleniminepolyplexforsirnamediatedlivercancertherapyincellmonolayerspheroidandtumorxenograftmodels
AT emilieheuillard performanceofpyridylthioureapolyethyleniminepolyplexforsirnamediatedlivercancertherapyincellmonolayerspheroidandtumorxenograftmodels
AT mathieugoncalves performanceofpyridylthioureapolyethyleniminepolyplexforsirnamediatedlivercancertherapyincellmonolayerspheroidandtumorxenograftmodels
AT francinegosse performanceofpyridylthioureapolyethyleniminepolyplexforsirnamediatedlivercancertherapyincellmonolayerspheroidandtumorxenograftmodels
AT ericrobinet performanceofpyridylthioureapolyethyleniminepolyplexforsirnamediatedlivercancertherapyincellmonolayerspheroidandtumorxenograftmodels
AT benoitfrisch performanceofpyridylthioureapolyethyleniminepolyplexforsirnamediatedlivercancertherapyincellmonolayerspheroidandtumorxenograftmodels
AT cendrineseguin performanceofpyridylthioureapolyethyleniminepolyplexforsirnamediatedlivercancertherapyincellmonolayerspheroidandtumorxenograftmodels
AT guyzuber performanceofpyridylthioureapolyethyleniminepolyplexforsirnamediatedlivercancertherapyincellmonolayerspheroidandtumorxenograftmodels